Span Divergent (BSE 524727)₹27.10−4.75%Pharmaceuticals
In the Jun 2026 quarter (consolidated), Span Divergent reported sales of ₹1.03 Cr, down 4.6% from Jun 2025, and net profit of −₹1.18 Cr. For the year to Mar 2026, sales were ₹17.28 Cr and net profit −₹2.94 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.19 | 3.02 | 3.04 | 3.72 | 2.81 | 1.91 | 0.56 | 1.08 | 7.67 | 3.87 | 4.66 | 1.03 |
| Expenses | 2.96 | 2.59 | 2.81 | 3.44 | 2.55 | 2.11 | 1.48 | 1.72 | 7.63 | 4.93 | 5.49 | 2.05 |
| Operating Profit | 0.20 | 0.40 | 0.20 | 0.25 | 0.23 | −0.21 | −0.93 | −0.65 | 0.00 | −1.07 | −0.85 | −1.03 |
| OPM % | 6.5% | 13.6% | 6.9% | 7.0% | 8.5% | −11.7% | −171.0% | −61.8% | 0.0% | −28.1% | −18.6% | −102.0% |
| Other Income | 0.28 | 0.37 | 0.97 | 0.21 | 0.26 | 0.48 | 0.35 | 0.92 | 0.23 | 0.35 | 0.16 | 0.29 |
| Interest | 0.19 | 0.19 | 0.18 | 0.17 | 0.16 | 0.15 | 0.16 | 0.13 | 0.13 | 0.12 | 0.13 | 0.15 |
| Depreciation | 0.46 | 0.33 | 0.32 | 0.27 | 0.29 | 0.29 | 0.23 | 0.26 | 0.28 | 0.29 | 0.31 | 0.25 |
| Profit before tax | −0.16 | 0.24 | 0.66 | 0.01 | 0.05 | −0.16 | −0.98 | −0.13 | −0.16 | −1.12 | −1.12 | −1.13 |
| Tax % | 76.4% | 71.9% | −32.9% | 550.0% | 16.6% | 23.5% | 4.0% | 21.4% | 11.7% | 0.9% | −0.9% | 3.5% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.29 | 0.05 | 0.87 | −0.08 | 0.04 | −0.20 | −1.02 | −0.16 | −0.17 | −1.12 | −1.11 | −1.18 |
| EPS (Rs) | −0.49 | 0.23 | 1.69 | −0.03 | 0.25 | −0.28 | −1.64 | −0.19 | −0.25 | −1.79 | −1.33 | −1.46 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 2.88 | 14.61 | 24.23 | 9.41 | 7.43 | 13.14 | 12.57 | 12.38 | 8.98 | 17.28 | 17.23 |
| Expenses | 5.21 | 8.34 | 25.10 | 31.25 | 15.13 | 9.62 | 12.64 | 11.39 | 10.92 | 9.58 | 19.76 | 20.10 |
| Operating Profit | −5.22 | −5.49 | −10.58 | −7.19 | −5.76 | −2.23 | 0.41 | 1.09 | 1.38 | −0.64 | −2.58 | −2.95 |
| OPM % | — | −191.7% | −72.8% | −29.9% | −61.7% | −30.4% | 3.2% | 8.8% | 11.2% | −7.3% | −15.1% | −17.1% |
| Other Income | 10.01 | 4.05 | 2.58 | −0.77 | 1.97 | 0.83 | −7.56 | −3.46 | 1.78 | 1.26 | 1.30 | 1.03 |
| Interest | 0.04 | 0.21 | 1.71 | 1.90 | 2.00 | 1.59 | 1.09 | 1.01 | 0.73 | 0.61 | 0.44 | 0.53 |
| Depreciation | 0.19 | 0.81 | 2.61 | 3.63 | 3.44 | 3.10 | 2.18 | 2.16 | 1.63 | 1.08 | 1.18 | 1.13 |
| Profit before tax | 4.52 | −2.47 | −12.27 | −13.44 | −9.23 | −6.09 | −10.34 | −5.50 | 0.79 | −1.08 | −2.89 | −3.53 |
| Tax % | 27.9% | 5.2% | 1.5% | 4.3% | −7.0% | 0.8% | −2.1% | −1.8% | 2.5% | 17.4% | 1.4% | — |
| Exceptional items | 6.99 | 2.99 | 0.99 | −1.99 | 0.00 | 0.00 | −8.98 | −3.99 | 0.99 | 0.00 | 0.00 | 0.00 |
| Net Profit | 3.27 | −2.60 | −12.47 | −14.01 | −8.59 | −6.15 | −10.13 | −5.40 | 0.78 | −1.27 | −2.94 | −3.58 |
| EPS (Rs) | 6.07 | −4.79 | −22.90 | −22.29 | −14.25 | −10.24 | −17.96 | −9.26 | 1.80 | −1.69 | −3.45 | −4.83 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.29 | 5.47 | 5.46 | 5.45 | 5.45 | 5.45 | 5.44 | 5.44 | 5.45 | 5.45 | 5.44 | 7.24 |
| Reserves | 54.55 | 44.83 | 43.19 | 30.60 | 19.88 | 12.11 | 6.57 | −3.23 | −8.29 | −7.36 | −8.28 | 7.61 |
| Borrowings | 0.35 | 0.20 | 13.15 | 23.22 | 22.31 | 19.20 | 18.00 | 13.20 | 11.16 | 9.12 | 8.37 | 7.15 |
| Other Liabilities | 3.82 | 0.44 | 2.98 | 4.04 | 1.65 | 2.54 | 4.25 | 12.26 | 17.00 | 16.66 | 17.32 | 6.94 |
| Total Liabilities | 66.01 | 50.94 | 64.78 | 63.31 | 49.29 | 39.30 | 34.26 | 27.67 | 25.32 | 23.87 | 22.85 | 28.94 |
| Fixed Assets | 2.19 | 2.14 | 8.13 | 25.84 | 22.41 | 20.11 | 17.65 | 15.31 | 13.07 | 10.71 | 9.61 | 9.30 |
| CWIP | 0.08 | 0.05 | 10.93 | 0.00 | 0.05 | 0.12 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 45.97 | 35.67 | 27.98 | 25.58 | 16.42 | 10.10 | 9.47 | 4.05 | 3.97 | 4.71 | 6.33 | 5.17 |
| Other Assets | 17.77 | 13.08 | 17.74 | 11.89 | 10.41 | 8.97 | 7.13 | 8.31 | 8.28 | 8.45 | 6.91 | 14.47 |
| Inventories | 0.22 | 0.00 | 1.35 | 3.54 | 2.59 | 1.10 | 0.61 | 1.77 | 1.60 | 1.17 | 0.99 | 1.73 |
| Trade receivables | 0.78 | 0.14 | 0.02 | 2.39 | 1.47 | 1.02 | 1.50 | 1.59 | 1.91 | 1.56 | 1.40 | 1.55 |
| Cash & equivalents | 9.76 | 3.17 | 5.34 | 1.77 | 1.89 | 0.46 | 0.83 | 0.18 | 0.39 | 0.92 | 1.03 | 6.95 |
| Total Assets | 66.01 | 50.94 | 64.78 | 63.31 | 49.29 | 39.30 | 34.26 | 27.67 | 25.32 | 23.87 | 22.85 | 28.94 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 60.89 | −7.37 | −5.37 | −11.75 | −7.08 | −0.11 | −0.22 | 7.04 | 1.97 | 2.51 | 1.87 | 0.23 |
| Cash from investing activity | −12.16 | 13.44 | −5.57 | 0.82 | 10.08 | 5.91 | 2.00 | −2.06 | 0.54 | 0.13 | −1.06 | 1.56 |
| Cash from financing activity | −42.13 | −12.15 | 12.72 | 7.35 | −2.81 | −7.31 | −1.40 | −5.49 | −2.29 | −2.08 | −1.14 | 4.11 |
| Net cash flow | 6.60 | −6.14 | 1.81 | −3.58 | 0.15 | −1.56 | 0.38 | −0.53 | 0.21 | 0.54 | −0.35 | 5.90 |
| Capex | 13.33 | 0.09 | 16.04 | 4.20 | 0.06 | 1.33 | 0.00 | 0.00 | 0.16 | 0.37 | 0.00 | 0.40 |
| Free cash flow | 47.46 | 3.90 | −21.42 | −15.11 | −6.92 | −1.45 | 1.78 | 8.11 | 1.84 | 2.11 | 1.90 | −0.18 |
| CFO / OP % | 5,865.0% | 102.0% | 13.1% | 60.0% | 97.0% | 0.0% | 3.0% | 1,717.0% | 185.1% | 183.1% | −185.0% | −15.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 4 | — | 1 | 60 | 22 | 39 | 73 | 44 | 55 | 46 | 57 | 33 |
| Inventory days | 3 | — | 314 | 101 | 52 | 84 | 143 | 179 | 318 | 206 | 123 | 40 |
| Days payable | 1 | — | 79 | 40 | 12 | 79 | 298 | 214 | 527 | 480 | 427 | 136 |
| Cash conversion cycle | 6 | — | 238 | 122 | 63 | 45 | −80 | 11 | −153 | −227 | −246 | −62 |
| Working capital days | −8 | — | −707 | −229 | −187 | −312 | −401 | −430 | −601 | −610 | −932 | −112 |
| ROCE % | −4.4% | −5.7% | −9.0% | −20.0% | −19.1% | −19.9% | −15.9% | −3.7% | −9.5% | 36.0% | −186.8% | −30.0% |
For the Jun 2026 quarter, Span Divergent reported sales of ₹1.03 Cr, down 4.6% year on year and net profit of −₹1.18 Cr. The operating margin was −102.0%.
Span Divergent's sales for the year to Mar 2026 were ₹17.28 Cr; over the last twelve months they were ₹17.23 Cr.
Net profit for the year to Mar 2026 was −₹2.94 Cr, and −₹3.58 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−4.83.
Span Divergent reported borrowings of ₹7.15 Cr at Mar 2026, against cash and equivalents of ₹6.95 Cr.
Cash from operations was ₹0.23 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.18 Cr.